tiprankstipranks
Advertisement
Advertisement

CAPR Stock Latest News

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts
Weekend UpdatesOTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts
22h ago
CAPR
CORT
Capricor Therapeutics price target lowered to $5 from $10 at B. Riley
PremiumThe Fly
Capricor Therapeutics price target lowered to $5 from $10 at B. Riley
2d ago
CAPR
Capricor Therapeutics downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Capricor Therapeutics downgraded to Hold from Buy at JonesResearch
2d ago
CAPR
Capricor Faces FDA Panel Setback on Deramiocel Therapy
PremiumCompany Announcements
Capricor Faces FDA Panel Setback on Deramiocel Therapy
2d ago
8K
CAPR
Capricor: FDA committee voted evidence did not support Deramiocel effectiveness
PremiumThe Fly
Capricor: FDA committee voted evidence did not support Deramiocel effectiveness
3d ago
CAPR
Humana upgraded, Las Vegas Sands downgraded: Wall Street’s top analyst calls
PremiumThe FlyHumana upgraded, Las Vegas Sands downgraded: Wall Street’s top analyst calls
3d ago
BE
PG
Capricor Therapeutics downgraded to Hold from Buy at Maxim
Premium
The Fly
Capricor Therapeutics downgraded to Hold from Buy at Maxim
3d ago
CAPR
Capricor Therapeutics downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Capricor Therapeutics downgraded to Perform from Outperform at Oppenheimer
3d ago
CAPR
Capricor Therapeutics downgraded to Neutral from Buy at Ladenburg
PremiumThe Fly
Capricor Therapeutics downgraded to Neutral from Buy at Ladenburg
3d ago
CAPR
Capricor downgraded to Neutral at Cantor with ‘unlikely’ path forward
PremiumThe Fly
Capricor downgraded to Neutral at Cantor with ‘unlikely’ path forward
3d ago
CAPR
Capricor Therapeutics resumes trading, shares sink 55% to $2.99
PremiumThe Fly
Capricor Therapeutics resumes trading, shares sink 55% to $2.99
3d ago
CAPR
Capricor Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Capricor Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
3d ago
CAPR
Capricor Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyCapricor Therapeutics downgraded to Neutral from Overweight at Piper Sandler
3d ago
CAPR
FDA panel votes 9-3 against Capricor’s deramiocel
Premium
The Fly
FDA panel votes 9-3 against Capricor’s deramiocel
3d ago
CAPR
Capricor downgraded to Neutral from Overweight at Cantor Fitzgerald
Premium
The Fly
Capricor downgraded to Neutral from Overweight at Cantor Fitzgerald
3d ago
CAPR
Lancet Validates Capricor’s HOPE-3 Duchenne Trial Results
PremiumCompany Announcements
Lancet Validates Capricor’s HOPE-3 Duchenne Trial Results
4d ago
8K
CAPR
Capricor Therapeutics announces publication of HOPE-3 data on deramiocel
PremiumThe Fly
Capricor Therapeutics announces publication of HOPE-3 data on deramiocel
4d ago
CAPR
Capricor Therapeutics downgraded to Neutral from Buy at Alliance Global
PremiumThe Fly
Capricor Therapeutics downgraded to Neutral from Buy at Alliance Global
5d ago
CAPR
Capricor Therapeutics downgraded to Neutral from Buy at Roth Capital
PremiumThe Fly
Capricor Therapeutics downgraded to Neutral from Buy at Roth Capital
5d ago
CAPR
Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
PremiumThe FlyMidday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
6d ago
F
GM
B. Riley downgrades Capricor as FDA briefing docs ‘incompatible with approval’
Premium
The Fly
B. Riley downgrades Capricor as FDA briefing docs ‘incompatible with approval’
6d ago
CAPR
Capricor says analyses in FDA’s briefing materials ‘rely on’ SAP version 1.1
Premium
The Fly
Capricor says analyses in FDA’s briefing materials ‘rely on’ SAP version 1.1
6d ago
CAPR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >